Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection
- 31 March 2011
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 174 (1-2) , 144-149
- https://doi.org/10.1016/j.jviromet.2011.03.027
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitroAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Decreased replication of human respiratory syncytial virus treated with the proteasome inhibitor MG-132Virus Research, 2010
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus InfectionPLOS ONE, 2010
- Respiratory Syncytial Virus Grown in Vero Cells Contains a Truncated Attachment Protein That Alters Its Infectivity and Dependence on GlycosaminoglycansJournal of Virology, 2009
- Respiratory Syncytial Virus Nonstructural Proteins Decrease Levels of Multiple Members of the Cellular Interferon PathwaysJournal of Virology, 2009
- Palmitoylation of the Influenza A Virus M2 Protein Is Not Required for Virus Replication In Vitro but Contributes to Virus VirulenceJournal of Virology, 2009
- Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic CellsJournal of Virology, 2009
- Human Respiratory Syncytial Virus Glycoproteins Are Not Required for Apical Targeting and Release from Polarized Epithelial CellsJournal of Virology, 2008
- In vitro study of the pulmonary translocation of nanoparticlesToxicology Letters, 2005
- Modes of transmission of respiratory syncytial virusThe Journal of Pediatrics, 1981